Abstract
Dr. Patrick Walsh’s description of nerve-sparing prostatectomy was an important landmark in the surgical treatment of prostate cancer. Despite the dramatic improvement in postoperative potency rates, anecdotal reports of penile size loss were increasingly reported by patients. Experimental studies in animals revealed penile fibrosis and corporal cavernosal smooth muscle apoptosis after cavernosal nerve ablation. After an observational cross-sectional study demonstrated a time-dependent loss of penile length and circumference in men presenting with erectile dysfunction after nerve-sparing prostatectomy, several prospective studies supported the observational study. A prospective penile biopsy study before and after surgery demonstrated replacement of corporal smooth muscle with collagen and provided a possible explanation for loss of penile length. The mechanism has not yet been elucidated. This article reviews in detail the existing studies on loss of penile size after prostatectomy and possible etiologic mechanisms.
Similar content being viewed by others
References and Recommended Reading
Walsh PC, Donker PJ: Impotence following radical prostatectomy: insight into etiology and prevention. J Urol 1982, 128:492–497.
Lepor H, Gregerman M, Crosby R, et al.: Precise localization of the autonomic nerves from the pelvic plexus to the corpora cavernosa: a detailed anatomical study of the adult male pelvis. J Urol 1985, 133:207–212.
Quinlan DM, Epstein JI, Carter BS, Walsh PC: Sexual function following radical prostatectomy: influence of preservation of neurovascular bundles. J Urol 1991, 145:998–1002.
Lee PA, Reiter EO: Genital size: a common adolescent male concern. Adolesc Med 2002, 13:171–180.
Stulhofer A: How (un)important is penis size for women with heterosexual experience? Arch Sex Behav 2006, 35:5–6.
Wessells H, Lue TF, McAninch JW: Penile length in the flaccid and erect states: guidelines for penile augmentation. J Urol 1996, 156:995–997.
Fraiman MC, Lepor H, McCullough AR: Changes in penile morphometrics in men with erectile dysfunction after nerve-sparing radical retropubic prostatectomy. Mol Urol 1999, 3:109–115.
O’Leary MP, Fowler FJ, Lenderking WR, et al.: A brief male sexual function inventory for urology. Urology 1995, 46:697–706.
Munding MD, Wessells HB, Dalkin BL: Pilot study of changes in stretched penile length 3 months after radical retropubic prostatectomy. Urology 2001, 58:567–569.
Savoie M, Kim SS, Soloway MS: A prospective study measuring penile length in men treated with radical prostatectomy for prostate cancer. J Urol 2003, 169:1462–1464.
Gontero P, Galzerano M, Bartoletti R, et al.: New insights into the pathogenesis of penile shortening after radical prostatectomy and the role of postoperative sexual function. J Urol 2007, 178:602–607.
Goodwin B, Brassil D, McCullough A: A 12 month interim analysis of the effect of nightly alprostadil vs sildenafil on penile morphometrics after nerve sparing radical prostatectomy. Presented at the Western Section American Urology Association Conference. Scottsdale, AZ; October 27–November 1, 2007.
Kovanecz I, Rambhatla A, Ferrini M, et al.: Long-term continuous sildenafil treatment ameliorates corporal veno-occlusive dysfunction (CVOD) induced by cavernosal nerve resection in rats. Int J Impot Res 2008, 20:202–212.
Kovanecz I, Rambhatla A, Ferrini MG, et al.: Chronic daily tadalafil prevents the corporal fibrosis and veno-occlusive dysfunction that occurs after cavernosal nerve resection. BJU Int 2008, 101:203–210.
Rambhatla A, Kovanecz I, Ferrini M, et al.: Rationale for phosphodiesterase 5 inhibitor use post-radical prostatectomy: experimental and clinical review. Int J Impot Res 2008, 20:30–34.
Briganti A, Fabbri F, Salonia A, et al.: Preserved postoperative penile size correlates well with maintained erectile function after bilateral nerve-sparing radical retropubic prostatectomy. Eur Urol 2007, 52:702–707.
Mulhall J: Can penile size be preserved after radical prostatectomy? Eur Urol 2007, 52:626–628.
Brow SL, Seftel AD, Strohl KP, Herbener TE: Vasculogenic impotence and cavernosal oxygen tension. Int J Impot Res 2000, 12:19–22.
Moreland RB: Is there a role of hypoxemia in penile fibrosis: a viewpoint presented to the Society for the Study of Impotence. Int J Impot Res 1998, 10:113–120.
Bannowsky A, Schulze H, van der Horst C, et al.: Erectile function after nerve-sparing radical prostatectomy. Nocturnal early erection as a parameter of postoperative organic erectile integrity [in German]. Urologe A 2005, 44:521–526.
Fraiman M, Lepor H, McCullough A: Nocturnal penile tumescence activity in 81 patients presenting with erectile dysfunction after nerve sparing radical prostatectomy. J Urol 1991, 161:179.
Moreland RB, Traish A, McMillin MA, et al.: PGE1 suppresses the induction of collagen synthesis by transforming growth factor-beta 1 in human corpus cavernosum smooth muscle. J Urol 1995, 153:826–834.
McCullough AR, Levine LA, Padma-Nathan H: Return of nocturnal erections and erectile function after bilateral nerve-sparing radical prostatectomy in men treated nightly with sildenafil citrate: subanalysis of a longitudinal randomized double-blind placebo-controlled trial. J Sex Med 2008, 5:476–484.
Klein LT, Miller MI, Buttyan R, et al.: Apoptosis in the rat penis after penile denervation. J Urol 1997, 158:626–630.
Rosenberg ME, Dvergsten J, Correa-Rotter R: Clusterin: an enigmatic protein recruited by diverse stimuli. J Lab Clin Med 1993, 121:205–214.
User HM, Hairston JH, Zelner DJ, et al.: Penile weight and cell subtype specific changes in a post-radical prostatectomy model of erectile dysfunction. J Urol 2003, 169:1175–1179.
Ciancio SJ, Kim ED: Penile fibrotic changes after radical retropubic prostatectomy. BJU Int 2000, 85:101–106.
Schwartz EJ, Wong P, Graydon RJ: Sildenafil preserves intracorporeal smooth muscle after radical retropubic prostatectomy. J Urol 2004, 171:771–774.
Iacono F, Giannella R, Somma P, et al.: Histological alterations in cavernous tissue after radical prostatectomy. J Urol 2005, 173:1673–1676.
Mulhall JP, Creech SD, Boorjian SA, et al.: Subjective and objective analysis of the prevalence of Peyronie’s disease in a population of men presenting for prostate cancer screening. J Urol 2004, 171:2350–2353.
Kadioglu A, Oktar T, Kandirali E, et al.: Incidentally diagnosed Peyronie’s disease in men presenting with erectile dysfunction. Int J Impot Res 2004, 16:540–543.
Gurkan L, Harbin A, Dorsey P, et al.: Ultrastructural changes of the tunica albuginea in response to cavernosal nerve injury in rats. Presented at the American Urological Association Conference. Orlando, FL; May 17–22, 2008.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
McCullough, A. Penile change following radical prostatectomy: Size, smooth muscle atrophy, and curve. Curr Urol Rep 9, 492–499 (2008). https://doi.org/10.1007/s11934-008-0084-2
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11934-008-0084-2